Peddock Capital Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,380
| Closed | -$16K | – | 291 |
|
|
2020
Q4 | $16K | Buy |
+3,380
| New | +$16K | 0.01% | 219 |
|
|
2020
Q1 | – | Sell |
-3,380
| Closed | -$15K | – | 238 |
|
|
2019
Q4 | $15K | Buy |
+3,380
| New | +$15K | 0.01% | 209 |
|
|
2019
Q2 | – | Sell |
-3,380
| Closed | -$14K | – | 235 |
|
|
2019
Q1 | $14K | Hold |
3,380
| – | – | 0.01% | 208 |
|
|
2018
Q4 | $12K | Hold |
3,380
| – | – | 0.01% | 216 |
|
|
2018
Q3 | $15K | Hold |
3,380
| – | – | 0.01% | 217 |
|
|
2018
Q2 | $13K | Hold |
3,380
| – | – | 0.01% | 220 |
|
|
2018
Q1 | $14K | Hold |
3,380
| – | – | 0.01% | 214 |
|
|
2017
Q4 | $20K | Hold |
3,380
| – | – | 0.01% | 206 |
|
|
2017
Q3 | $15K | Hold |
3,380
| – | – | 0.01% | 214 |
|
|
2017
Q2 | $13K | Buy |
+3,380
| New | +$13K | 0.01% | 220 |
|